awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36682845-6B16286D-3286-4711-A5BA-4CBCF04C0FCB
Q36682845-6B16286D-3286-4711-A5BA-4CBCF04C0FCB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36682845-6B16286D-3286-4711-A5BA-4CBCF04C0FCB
A phase II study of decitabine and gemtuzumab ozogamicin in newly diagnosed and relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome.
P2860
Q36682845-6B16286D-3286-4711-A5BA-4CBCF04C0FCB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36682845-6B16286D-3286-4711-A5BA-4CBCF04C0FCB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a836c0e4926b1513f5e87e95c7d01b41641548b9
P2860
A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemia.